Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world / Kapelios, C.J., Lainscak, M., Savarese, G., Laroche, C., Seferovic, P., Ruschitzka, F., Coats, A., Anker, S.D., Crespo-Leiro, M.G., Filippatos, G., Piepoli, M.F., Rosano, G., Zanolla, L., Aguiar, C., Murin, J., Leszek, P., Mcdonagh, T., Maggioni, A.P., Lund, L.H., Auer, J., et al.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2019). [10.1002/ejhf.1532]

Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

Metra M.;
2019-01-01

2019
Inglese
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1879-0844
Angiotensin receptor–neprilysin inhibitor
Eligibility
LCZ696
Prognosis
Registry
Sacubitril/valsartan
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world / Kapelios, C.J., Lainscak, M., Savarese, G., Laroche, C., Seferovic, P., Ruschitzka, F., Coats, A., Anker, S.D., Crespo-Leiro, M.G., Filippatos, G., Piepoli, M.F., Rosano, G., Zanolla, L., Aguiar, C., Murin, J., Leszek, P., Mcdonagh, T., Maggioni, A.P., Lund, L.H., Auer, J., et al.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2019). [10.1002/ejhf.1532]
none
618
info:eu-repo/semantics/article
262
Kapelios, C. J.; Lainscak, M.; Savarese, G.; Laroche, C.; Seferovic, P.; Ruschitzka, F.; Coats, A.; Anker, S. D.; Crespo-Leiro, M. G.; Filippatos, G.;...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/193440
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 34
social impact